Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Bernstein Reiterates Market Perform Rating on ConAgra (CAG)
-
Chipotle Mexican Grill (CMG) PT Lowered as Bernstein Predicts 3Q25 Miss
-
Bernstein Reiterates Underperform Rating on Deckers Outdoor (DECK)
-
Bernstein SocGen Group Starts Rightmove Plc. (RMV:LN) (RTMVY) at Outperform
-
Epilepsy Foundation of America Welcomes Four New Members to National Board of Directors
-
Valor PayTech Announces Strategic Investment from Lovell Minnick Partners to Accelerate Growth
-
Peloton shares jump after AI-driven overhaul
-
Bernstein on Thermo Fisher Scientific (TMO): 'Is Now the Time To Invest?... Buy the Strength'
-
Bernstein Calls Boston Scientific (BSX) a 'Great Stock Story'
-
Lamb Weston (LW) PT Raised to $65 at Bernstein, as 'Management Rebounds on Execution'
-
Bernstein on Nike (NKE): 'The Momentum Builds...'
-
Bernstein Reiterates Market Perform Rating on Carnival Corporation (CCL)
-
Bernstein SocGen Group Reiterates Outperform Rating on Chico's, Inc. (CHS)
-
China’s electrification push keeps this stock as a top pick: Bernstein
-
Summa Health and HATCo Finalize Transaction, Launch Vision to Transform Healthcare in Akron and Beyond
-
US Pfizer deal powers health stocks as drugmakers court Trump
-
Bernstein SocGen Group Starts Borouge PLC (BOROUGE:UH) at Market Perform
-
Novartis wins FDA approval for oral chronic urticaria treatment
-
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
-
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
-
US drugmakers rise after Trump announces Pfizer price cuts
-
Generational Group Advises Commercial Driver Services, Inc. in its Sale to TransTech, Inc.
-
Bernstein sees 'a strong buying opportunity' in this U.S. medical stock
-
Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
-
Bernstein: 'Should Netflix (NFLX) Acquire WBD?'
-
Bernstein on Carnival Corporation (CCL): 'Another Beat and Raise, but Q4 Slightly Below Street'
-
Norfolk Southern (NSC) PT Raised to $347 at Bernstein SocGen Group
-
Bernstein: 'What Investors Are Asking and Missing About Diamondback Energy (FANG)'
-
This is the hottest stock in Europe says Bernstein
-
Bernstein SocGen Group Reiterates Outperform Rating on Puma SE (PUM:GR) (PMMAF)
-
Bernstein SocGen Group Downgrades Square Enix Holdings (9684:JP) (SQNNY) to Underperform
-
Konami Holdings Corp. (9766:JP) (KNMCY) PT Raised to JPY25,800 at Bernstein SocGen Group
-
Bernstein SocGen Group Downgrades Quadient SA (QDT:FP) to Market Perform
-
Eutelsat needs to close funding gap to gain ground on Starlink
-
Bernstein SocGen Group Upgrades Brunello Cucinelli SpA (BC:IM) (BCUCF) to Outperform
-
This is Bernstein's top lodging stock
-
Bernstein says Donald Trump wants this stock to go up
-
Carnival raises annual profit forecast on resilient cruise demand, high costs loom
-
CARNIVAL CORPORATION & PLC ACHIEVES ALL-TIME HIGH FINANCIAL RESULTS WITH NET INCOME OF $1.9 BILLION (ADJUSTED NET INCOME OF $2 BILLION)
-
Bernstein on Semiconductors: 'Own Both NVDA and AVGO; Donald Trump Wants Intel To Go Up?'
-
Bernstein Reiterates Market Perform Rating on Five Below (FIVE)
-
Bernstein on Intuitive Surgical (ISRG): 'We See a Strong Buying Opportunity Here'
-
Bernstein on Wingstop (WING): 'Why Investors Should Not Panic'
-
Bernstein Reiterates Outperform Rating on CRH plc (CRH) Ahead of CMD
-
Bernstein says this company is now the most visible way of investing in Gen AI success
-
OTA stocks: Q3 earnings preview
-
Bernstein Private Wealth Management Named Financial Advisor Team of the Year at the 2025 Society for Trusts & Estate Practitioners Private Client Awards
-
Baidu (BIDU) PT Raised to $150 at Bernstein SocGen Group
-
Heineken (HEIA:NA) (HEINY) PT Lowered to EUR118 at Bernstein SocGen Group
-
Costco Wholesale (COST) PT Raised as Bernstein Recommends 'Buy on Weakness'

